Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
De incidentie van COVID-19-geassocieerde pulmonale aspergillose in het vaccinatietijdperk
feb 2024 | Schimmelinfecties, Vaccinatie, Virale infecties